Perfil
Irackly Mtibelishvily worked as a Director at Argos Therapeutics, Inc. from 2016 to 2018.
He graduated from Moscow State Institute of International Relations and the University of Virginia School of Law with graduate degrees.
Antiguos cargos conocidos de Irackly Mtibelishvily.
| Empresas | Cargo | Fin |
|---|---|---|
| ARGOS THERAPEUTICS, INC. | Director/Miembro de la Junta | 30/11/2018 |
Formación de Irackly Mtibelishvily.
| University of Virginia School of Law | Graduate Degree |
| Moscow State Institute of International Relations | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
- Bolsa de valores
- Insiders
- Irackly Mtibelishvily
